These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34693253)

  • 21. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Multiple Plasma Biomarker Concentrations with Progression of Prevalent Diabetic Kidney Disease: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Schrauben SJ; Shou H; Zhang X; Anderson AH; Bonventre JV; Chen J; Coca S; Furth SL; Greenberg JH; Gutierrez OM; Ix JH; Lash JP; Parikh CR; Rebholz CM; Sabbisetti V; Sarnak MJ; Shlipak MG; Waikar SS; Kimmel PL; Vasan RS; Feldman HI; Schelling JR;
    J Am Soc Nephrol; 2021 Jan; 32(1):115-126. PubMed ID: 33122288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble urokinase plasminogen activator receptor and decline in kidney function among patients without kidney disease.
    Iversen E; Kallemose T; Hornum M; Bengaard AK; Nehlin JO; Rasmussen LJH; Sandholdt H; Tavenier J; Feldt-Rasmussen B; Andersen O; Eugen-Olsen J; Houlind MB
    Clin Kidney J; 2022 Aug; 15(8):1534-1541. PubMed ID: 35892012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of Rapid Progression of Glomerular and Nonglomerular Kidney Disease in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort.
    Warady BA; Abraham AG; Schwartz GJ; Wong CS; Muñoz A; Betoko A; Mitsnefes M; Kaskel F; Greenbaum LA; Mak RH; Flynn J; Moxey-Mims MM; Furth S
    Am J Kidney Dis; 2015 Jun; 65(6):878-88. PubMed ID: 25799137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urokinase plasminogen activator receptor and its soluble form in common biopsy-proven kidney diseases and in staging of diabetic nephropathy.
    Wu CZ; Chang LC; Lin YF; Hung YJ; Pei D; Chu NF; Chen JS
    Clin Biochem; 2015 Dec; 48(18):1324-9. PubMed ID: 26162494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soluble urokinase plasminogen activator receptor levels are elevated and associated with complications in patients with type 1 diabetes.
    Theilade S; Lyngbaek S; Hansen TW; Eugen-Olsen J; Fenger M; Rossing P; Jeppesen JL
    J Intern Med; 2015 Mar; 277(3):362-371. PubMed ID: 24830873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between Soluble Urokinase-Type Plasminogen Activator Receptor Levels and Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
    Shuai T; Yan P; Xiong H; Huang Q; Zhu L; Yang K; Liu J
    Biomed Res Int; 2019; 2019():6927456. PubMed ID: 31886242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Aptamer-Based and Antibody-Based Assays for Protein Quantification in Chronic Kidney Disease.
    Lopez-Silva C; Surapaneni A; Coresh J; Reiser J; Parikh CR; Obeid W; Grams ME; Chen TK
    Clin J Am Soc Nephrol; 2022 Mar; 17(3):350-360. PubMed ID: 35197258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes.
    Rotbain Curovic V; Theilade S; Winther SA; Tofte N; Eugen-Olsen J; Persson F; Hansen TW; Jeppesen J; Rossing P
    Diabetes Care; 2019 Jun; 42(6):1112-1119. PubMed ID: 30885954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated Soluble Urokinase Plasminogen Activator Receptor and Proenkephalin Serum Levels Predict the Development of Acute Kidney Injury after Cardiac Surgery.
    Mossanen JC; Pracht J; Jansen TU; Buendgens L; Stoppe C; Goetzenich A; Struck J; Autschbach R; Marx G; Tacke F
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28758975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperuricemia and Progression of CKD in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort Study.
    Rodenbach KE; Schneider MF; Furth SL; Moxey-Mims MM; Mitsnefes MM; Weaver DJ; Warady BA; Schwartz GJ
    Am J Kidney Dis; 2015 Dec; 66(6):984-92. PubMed ID: 26209544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of income level with kidney disease severity and progression among children and adolescents with CKD: a report from the Chronic Kidney Disease in Children (CKiD) Study.
    Hidalgo G; Ng DK; Moxey-Mims M; Minnick ML; Blydt-Hansen T; Warady BA; Furth SL
    Am J Kidney Dis; 2013 Dec; 62(6):1087-94. PubMed ID: 23932090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating Soluble Urokinase Plasminogen Activator Receptor as a Predictive Indicator for COVID-19-Associated Acute Kidney Injury and Mortality: Clinical and Bioinformatics Analysis.
    Abdellatif HAA; Sultan BO; Nassar HM; Gomaa MEE; Sakr MG; Riad E; Al-Harbi AI; Abdulhakim JA; Fawzy MS; Abd El-Fadeal NM
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimating Time to ESRD in Children With CKD.
    Furth SL; Pierce C; Hui WF; White CA; Wong CS; Schaefer F; Wühl E; Abraham AG; Warady BA; ;
    Am J Kidney Dis; 2018 Jun; 71(6):783-792. PubMed ID: 29653769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting Mortality in African Americans With Type 2 Diabetes Mellitus: Soluble Urokinase Plasminogen Activator Receptor, Coronary Artery Calcium, and High-Sensitivity C-Reactive Protein.
    Hayek SS; Divers J; Raad M; Xu J; Bowden DW; Tracy M; Reiser J; Freedman BI
    J Am Heart Assoc; 2018 May; 7(9):. PubMed ID: 29716888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated suPAR Is an Independent Risk Marker for Incident Kidney Disease in Acute Medical Patients.
    Iversen E; Houlind MB; Kallemose T; Rasmussen LJH; Hornum M; Feldt-Rasmussen B; Hayek SS; Andersen O; Eugen-Olsen J
    Front Cell Dev Biol; 2020; 8():339. PubMed ID: 32596235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Time-Varying Blood Pressure With Chronic Kidney Disease Progression in Children.
    Reynolds BC; Roem JL; Ng DKS; Matsuda-Abedini M; Flynn JT; Furth SL; Warady BA; Parekh RS
    JAMA Netw Open; 2020 Feb; 3(2):e1921213. PubMed ID: 32058554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating miR-10b, soluble urokinase-type plasminogen activator receptor, and plasminogen activator inhibitor-1 as predictors of non-small cell lung cancer progression and treatment response.
    Setiawan L; Setiabudy R; Kresno SB; Sutandyo N; Syahruddin E; Jovianti F; Nadliroh S; Mubarika S; Setiabudy R; Siregar NC
    Cancer Biomark; 2024; 39(2):137-153. PubMed ID: 38073374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomarkers During Recovery From AKI and Prediction of Long-term Reductions in Estimated GFR.
    Wilson M; Packington R; Sewell H; Bartle R; McCole E; Kurth MJ; Richardson C; Shaw S; Akani A; Banks RE; Selby NM
    Am J Kidney Dis; 2022 May; 79(5):646-656.e1. PubMed ID: 34653541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Self-reported Race, Serum Creatinine, Cystatin C, and GFR in Children and Young Adults With Pediatric Kidney Diseases: A Report From the Chronic Kidney Disease in Children (CKiD) Study.
    Ng DK; Furth SL; Warady BA; Crews DC; Seegmiller JC; Schwartz GJ;
    Am J Kidney Dis; 2022 Aug; 80(2):174-185.e1. PubMed ID: 34974031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.